NSN 6505-01-164-8736
Part Details | THEOPHYLLINE EXTENDED-RELEASE CAPSULES
6505-01-164-8736
Alternate Parts: NDC00075030000, NDC00075-0300-00, NDC00067030068, NDC00067-0300-68, SLOBID GYROCAPS, SLO-BID GYROCAPS, SLOBID, SLO-BID, NDC00603595221, NDC00603-5952-21, NDC00258362501, NDC00258-3625-01, NDC00904784960, NDC00904-7849-60, 6505-01-164-8736, 01-164-8736, 6505011648736, 011648736
Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
---|---|---|---|
65 | OCT 21, 1983 | 01-164-8736 | 42774 ( THEOPHYLLINE EXTENDED-RELEASE CAPSULES ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-164-8736
Part Number | Cage Code | Manufacturer |
---|---|---|
NDC00075-0300-00 | 04518 | AVENTIS PHARMACEUTICALS PRODUCTSINC. |
NDC00067-0300-68 | 04518 | AVENTIS PHARMACEUTICALS PRODUCTSINC. |
SLO-BID GYROCAPS | 04518 | AVENTIS PHARMACEUTICALS PRODUCTSINC. |
SLO-BID | 04518 | AVENTIS PHARMACEUTICALS PRODUCTSINC. |
NDC00603-5952-21 | 0ET99 | GENERICS BIDCO I, LLCDBA PAR PHARMACEUTICAL |
NDC00258-3625-01 | 6X308 | INWOOD LABORATORIES INC |
NDC00904-7849-60 | 0SYT3 | MAJOR PHARMACEUTICALS INC |
Technical Data | NSN 6505-01-164-8736
Characteristic | Specifications |
---|---|
CAPSULE TYPE | |
CAPSULE CONTENT FORM | |
ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB300.000 MILLIGRAMS THEOPHYLLINE |
PRIMARY CONTAINER TYPE | BOTTLE |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
THERAPEUTIC EQUIVALENT | SLO-BID GYROCAPS BY RORER PHARMACEUTICAL |
SPECIAL FEATURES | ANHYDROUS |
PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S |